• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors




Stuart C. Gordon, MD

Latest:

Late Diagnosis of Hepatitis C Virus Infection, 2014-2016: Continuing Missed Intervention Opportunities

Late hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.



Bevanne Bean-Mayberry, MD, MHS

Latest:

Organization of Care and Diagnosed Depression Among Women Veterans

This analysis studies effects of practice structures, primary care and mental health integration, and sex-specific primary care services on diagnosis of depression among women veterans.


Pamela Roberto, PhD

Latest:

Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment

Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.



Andrea Hassol, MSPH

Latest:

Enhancing Patient and Family Engagement Through Meaningful Use Stage 3: Opportunities and Barriers to Implementation

Two leading US health systems attempted to implement 4 draft objectives for Meaningful Use Stage 3 within their health IT infrastructure to provide feedback on needed enhancements to the policy.


Judith Kutzleb, DNP

Latest:

Study: Health Recovery Solutions Uses Tablets to Reduce Cardiac Readmissions

Pilot program implemented at Hackensack ACO that provides hospitals and ACOs an early warning system to manage their highest risk patients.


Daniel A. Handel, MD, MBA, MPH

Latest:

Inpatient Placement: Associations With Mortality, Cost, and Length of Stay

Placement of patients in an inpatient hospital setting is associated with lower length of stay and mortality at the expense of higher costs.





Melinda B. Buntin, PhD

Latest:

Risk Adjusting for Medicaid Participation in Medicare Advantage

When comparing risk-adjustment approaches based on Medicaid status of Medicare beneficiaries, this analysis found that predicted spending levels varied depending on states’ Medicaid eligibility criteria.



Allison B. Rosen, MD, MPH, ScD

Latest:

Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?

A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.





Jill Mesa

Latest:

A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery

This pharmacist-led, patient-directed intervention demonstrated a reduction in opioid dispensings in the 90 days following hip replacement but not knee replacement.


Lisa C. Richardson, MD, MPH

Latest:

Visit Duration for Outpatient Physician Office Visits Among Patients With Cancer

Higher use of performance-based payment mechanisms and capitated arrangements is associated with a decrease in the amount of time physicians spend with patients with cancer.


Bernard J. Gersh, MBChB, DPhil

Latest:

Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents

Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.





Emily Meredith Gillen, PhD

Latest:

The Effect of Narrow Network Plans on Out-of-Pocket Cost

The authors examined the effect of narrow network plan selection on beneficiaries’ outpatient visits and outpatient out-of-pocket expenditures in the 2014 nongroup health insurance market.


Katie Jean Sullivan

Latest:

Consumers to See Star-Ranking System in Healthcare Insurance

Starting in fall 2013, US consumers can expect to see more health insurers utilizing a star-rating system. The new approach in healthcare coverage aims to reflect the quality of insurance plans in relation to costs for policy holders.


Megan Mathews, MA

Latest:

The Development of a Patient-Reported Functional Limitations Index

We describe an easy-to-interpret, patient-reported Functional Limitations Index that can be used to monitor care of patients along the disability continuum.


Leslie Kane, MA

Latest:

Areas of Addressable Friction for the Adoption of Greater Healthcare Affordability: Insights from US Physicians

Based on an analysis of Medscape Business of Medicine data, we identify 5 specific areas of friction for the success of payment reform efforts.


Margaret Youngmi Pio, PharmD, BCPS, CDE

Latest:

Impact of Clinical Pharmacy Services on Outcomes and Costs for Indigent Patients With Diabetes

Clinical pharmacy specialists impact patient care through improvements in clinical outcomes for diabetes, hypertension, and dyslipidemia via clinical interventions and promotion of medication adherence.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.